Menu
Nosso webinar tem como foco apresentar os avanços na caracterização do perfil molecular de tumores. Contaremos com palestras e discussões envolvendo nossos gerentes de produtos e especialistas no assunto, abordando os seguintes tópicos:
Após as apresentações, teremos salas individuais para discussões mais profundas sobre cada tópico com os gerentes de produto.
Nosso objetivo é abordar os principais desafios no perfil de tumor molecular, fornecendo insights e trazendo inovações nesse assunto.
Agenda:
16:00 SOPHiA's mission to democratize data-driven medicine
Heitor Barros, MSc – Sr. SBDM - SOPHiA GENETICS
Ana Korbes, PhD – SME – SOPHiA GENTICS
16:15 Novel approach to rapid and accurate fusion detection in Solid tumors
Mikhail Pertziger, PhD - Product Manager – SOPHiA GENETICS
16:45 A decentralized HRD (Homologous recombination deficiency) solution
David Schlesinger, PhD - Senior Clinical Application Product Manager - SOPHiA GENETICS
17:15 Beyond the molecular – Radiomics for oncology
Jeff Gaudet, PhD – Sr. SME – SOPHiA GENETICS
17:45 Closing
Gabrielle Martins, MSc. – SBDM – SOPHiA GENETICS
18:00 Breakout rooms (Discussion)
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
